TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 73 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $777 | -99.8% | 31,934 | +147.9% | 0.00% | – |
| Q3 2022 | $386,000 | -55.1% | 12,881 | -45.8% | 0.00% | -100.0% |
| Q2 2022 | $859,000 | +108.5% | 23,757 | +315.3% | 0.00% | – |
| Q2 2021 | $412,000 | -39.9% | 5,720 | -38.4% | 0.00% | – |
| Q1 2021 | $685,000 | +108.2% | 9,291 | +55.1% | 0.00% | – |
| Q3 2020 | $329,000 | +3.5% | 5,991 | +25.4% | 0.00% | – |
| Q2 2020 | $318,000 | -92.7% | 4,776 | -90.4% | 0.00% | -100.0% |
| Q4 2019 | $4,382,000 | -29.5% | 49,833 | -39.5% | 0.01% | -50.0% |
| Q3 2019 | $6,216,000 | +167.1% | 82,391 | +202.5% | 0.01% | +233.3% |
| Q2 2019 | $2,327,000 | +111.9% | 27,241 | +168.3% | 0.00% | +50.0% |
| Q1 2019 | $1,098,000 | -23.1% | 10,154 | -39.8% | 0.00% | 0.0% |
| Q4 2018 | $1,427,000 | +210.2% | 16,862 | +260.6% | 0.00% | +100.0% |
| Q3 2018 | $460,000 | -92.8% | 4,676 | -91.6% | 0.00% | -87.5% |
| Q2 2018 | $6,414,000 | -38.1% | 55,444 | -47.1% | 0.01% | -42.9% |
| Q1 2018 | $10,354,000 | -3.1% | 104,861 | +2.7% | 0.01% | -6.7% |
| Q4 2017 | $10,688,000 | +1481.1% | 102,074 | +1592.5% | 0.02% | +1400.0% |
| Q2 2017 | $676,000 | -82.6% | 6,031 | -82.9% | 0.00% | -85.7% |
| Q3 2016 | $3,888,000 | -9.9% | 35,182 | +16.8% | 0.01% | -36.4% |
| Q1 2016 | $4,314,000 | -16.5% | 30,114 | -16.7% | 0.01% | +10.0% |
| Q3 2015 | $5,164,000 | -48.0% | 36,138 | -47.7% | 0.01% | -47.4% |
| Q2 2015 | $9,932,000 | -59.5% | 69,119 | -60.3% | 0.02% | -58.7% |
| Q1 2015 | $24,538,000 | +9.6% | 173,991 | +15.2% | 0.05% | -2.1% |
| Q4 2014 | $22,388,000 | +184.9% | 151,077 | +195.8% | 0.05% | +135.0% |
| Q3 2014 | $7,859,000 | +979.5% | 51,082 | +884.2% | 0.02% | +900.0% |
| Q2 2014 | $728,000 | +128.2% | 5,190 | +61.1% | 0.00% | +100.0% |
| Q4 2013 | $319,000 | -28.8% | 3,221 | -45.4% | 0.00% | 0.0% |
| Q3 2013 | $448,000 | – | 5,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |